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Summary 
In rats with a un i la tera l  6-OHDA lesion of the substantia nigra 
exposure to footshock or immobilization stress produced a long- 
last ing enhancement in the rotat ional  behavior evoked by a sub- 
sequent in jec t ion  of amphetamine. However, the e f fec t  was 
dependent on the environmental context in which stress was applied. 
I t  is suggested that stress may induce enduring changes in brain 
and behavior s imi lar  to those produced by psychomotor stimulant 
drugs. 
The repeated in termi t ten t  administrat ion of psychomotor stimulant drugs, 
such as amphetamine (AMPH) or cocaine, produces a progressive and enduring 
enhancement in many dopamine-mediated behaviors. This phenomenon is known as 
behavioral sens i t i za t ion ,  or "reverse tolerance" ( for  reviews see I ,  2, 3). 
However, i t  has been suggested that the behavioral sens i t iza t ion produced by 
stimulants may not be unique to the psychopharmacology of st imulants, but due 
to t he i r  action as stressors (4, 5, 6). This is because repeated in termi t ten t  
stress also produces sens i t i za t i on - l i ke  ef fects  (7, 8). More important, 
previous exposure to a var ie ty  of stressors (e .g . ,  t a i l  pinch, footshock, 
immobil ization) enhances the behavioral response to a subsequent in jec t ion  of 
AMPH or cocaine ( I ,  9, I0) .  
In previous studies of stress-st imulant drug interact ions behaviors that 
can occur in the absence of act ive locomotion (e .g . ,  stereotyped sn i f f i ng ,  
dr inking) were measured to assess the inf luence of previous stress. Since 
stress, and especial ly  footshock stress, often decreases act ive locomotion ( I I )  
we thought i t  important to determine i f  previous stress would also enhance an 
AMPH-induced behavior requir ing act ive locomotion. Therefore, we have studied 
the ef fects of footshock or immobilization stress on AMPH-induced rotat ional  
behavior in rats with a un i la tera l  6-hydroxydopamine (6-OHDA) lesion of the 
substantia nigra (12). 
Methods 
Female Holtzman rats weighing 185-200 g at the time of surgery were 
housed singly on a reversed l igh t /dark  cycle. Food and water were f ree ly  
avai lable.  Each rat  was anesthetized with sodium pentobarbital 30 min a f te r  
pretreatment with desipramine HCI (Merrell-Dow Pharmaceuticals; 13), and a 30 
gauge cannula placed into the zona compacta of the r igh t  substantia nigra 
using standard stereotaxic techniques. To un i l a te ra l l y  destroy the dopamine 
(DA)-containing ce l ls  on that side 8 ~g of 6-OHDA HBr was infused through the 
cannula in 4 ~I of a 0.9% sal ine solut ion that also contained ascorbate (0.I  
mg/ml), at a rate of 0.5 ~I/min. 
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After  a 1 month recovery period, the animals were randomly assigned to 1 
of 5 treatment groups, which w i l l  be referred to as the: ( I )  Shock-Rotometer 
(SK-R); (2) Shock-Unique (SK-U); (3) Shock-Control; (4) Immobil ization (IM); or 
(5) Immobil ization-Control groups. These groups received one of the fol lowing 
treatments on each of 5 consecutive days. Animals in the Shock-Rotometer 
group (n=20) were placed in automated rotometers s im i la r  to those described by 
Greenstein and Glick (14), but with a f l a t  gr id f l oo r  through which footshock 
could be applied. Af ter  a I0 min habituation period each rat  received 20 min 
of discontinuous footshock stress (1.3 mA, 0.5 sec duration with 15 sec 
between shocks), and were then returned to the i r  home cages. Animals in the 
Shock-Unique group (n=19) were treated exact ly as those in the Shock-Rotometer 
group, except they received footshock stress in a unique environment; i . e . ,  not 
in the rotometers. The environment in which they received shock was made very 
d i s t i nc t  from that in which the rotometers were located, including red (vs. 
white) l i g h t  condit ions, str iped (vs. c lear) chambers, auditory s t imul i  (music) 
and o l fac tory  s t imul i  ("Jasmine oi l " -scented wood shavings). Shock-Control 
animals (n=13) were also placed in rotometers for  30 min but did not receive 
any footshock. The rats in the Immobil ization (n=20) group were weighed and 
then i nd i v i dua l l y  wrapped in a cloth towel and l e f t  in an open area for  3 
hours each day. The Immobil ization-Control animals were simply weighed on each 
of the 5 days. 
Ten days a f te r  the las t  stress or control treatment each rat  was placed in 
an automated rotometer with a so l id  f l a t  f l oo r  and allowed to habituate for  15 
min. Following the habituation period a l l  animals received an i .p .  in jec t ion 
of d-amphetamine su l fa te  (3.0 mg/kg) and rotat ional  behavior recorded during 
each subsequent 5 min in terva l  for  a to ta l  of 2.25 hrs. 
At least one week a f te r  being tested for  AMPH-induced ro ta t ion ,  the rats 
were k i l l ed  by decapitat ion, the l e f t  and r igh t  s t r i a ta  removed and la te r  
assayed separately for  dopamine (DA) by high performance l i qu id  chromatography 
with electrochemical detection (15). Only animals that had an 85% or greater 
DA depletion in the r igh t  str iatum ( re l a t i ve  to the l e f t )  and turned i p s i -  
versive were used in the fol lowing analysis (see 16 for  ra t iona le) .  The N's 
given above do not include the s ix  animals that fa i led  to meet th is  c r i t e r i on .  
Results 
The Shock-Control and Immobil ization-Control groups did not d i f f e r  
s t a t i s t i c a l l y  (2-way ANOVA, F values < 1.0), and therefore they were pooled to 
form one Control (C) group. Fig. 1 shows the number of rotat ions made during 
each 5 min in terva l  over the 15 min habituation period and the 2.25 hr period 
a f te r  AMPH administrat ion for  these Control animals, and animals in each of the 
experimental groups. Each experimental group was compared to the Control group 
using 2-way analyses of variance. 
Animals that were previously exposed to footshock in the rotometers (SK-R) 
did not d i f f e r  s i g n i f i c a n t l y  from the Control animals in AMPH-induced 
rotat ional  behavior, and in fac t ,  made s l i g h t l y  fewer AMPH-induced rotat ions 
than Controls (Fig. I ;  F = 1.2). The tendancy of animals previously shocked in 
the rotometers to freeze when subsequently placed in the rotometers is 
indicated by a decrease in the rate of spontaneous rotat ion during the 15 min 
habituation period, r e l a t i ve  to Control animals. Shock-Rotometer animals made 
an average (± S.E.M.) of 2.2 ±0.9, 2.2 ± 0.7, and 1.8 ± 0.6 spontaneous 
rotat ions during the three 5 min habituation in te rva ls ,  whereas Control animals 
made 5.8 ± 1.2, 4.5 ± 0.8, and 2.6 ± 0.6 rotat ions (Main e f fec t  F = 6.0, 
p = .019; in teract ion F = 2.4, p = . I0 ) .  In contrast,  rats that had been 
previously exposed to immobil ization stress (IM vs. C in teract ion F = 5.9, 
p < 0.001) or to footshock stress in an unique environment (SK-U vs. C in te r -  
action F = 1.9, p = 0.005) made s i g n i f i c a n t l y  more AMPH-induced rotat ions than 
Control animals (Fig. I ) .  These l a t t e r  three groups did not d i f f e r  in t he i r  
rate of spontaneous rotat ion during the habituation period. In addi t ion,  
animals in the Shock-Unique group made more AMPH-induced rotat ions than those 
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in the Shock-Rotometer group (F = 2.2, p < 0.001). The significant inter- 
actions indicate that the groups did not dif fer over the entire test session, 
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Fi 9. I. Average rotations per 5 min interval for control rats (C; see text), 
and rats previously exposed to immobilization stress (IM), footshock stress in 
the rotometers (Shock-Rotometer; SK-R) or footshock stress in an unique 
environment (Shock-Unique; SK-U). One rotation consists of 4 consecutive 90 ° 
turns in the same direction. Both spontaneous rotational behavior during the 
15 min habituation period (intervals -3 to - l )  and rotational behavior 
induced by 3.0 mg/kg of AMPH (intervals l to 27) are illustrated. The 
asterisks indicate groups that differed from the control group in AMPH-induced 
rotational behavior. 
Discussion 
The results reported here support earlier claims that prior exposure to 
stress, like prior exposure to AMPH, enhances stimulant drug-induced behavior 
( l ,  4, 9). Furthermore, this phenomenon is not limited to behavior that can 
occur in the absence of active locomotion (e.g., stereotypy), but includes 
behavior requiring active locomotion. Since these experiments were completed, 
Herman et al. (17) reported that footshock stress also enhances the locomotor 
response (measured in photocell cages) to AMPH given 24 hr after the last 
stress session. However, i t  should be noted that the environmental context in 
which stress is applied can have a large effect on the outcome of these types 
of experiments. Environmental context is also an important variable in 
studies of behavioral sensitization to AMPH (e.g., 18, 19). 
The fact that stimulants and stress have similar enduring effects on 
behavior suggests that they may also have similar enduring effects on brain. 
I t  is known that acute treatment with either stimulants or stress produces 
comparable effects on brain activity and the hypothalamo-pituitary-adrenal 
axis (reviewed in l and 5). Unfortunately, we know l i t t l e  about the long-term 
changes in brain produced by either stimulants or stress. However, i t  has 
recently been found that the repeated intermittent administration of AMPH 
produces an enduring enhancement in mesocortical DA uti l ization (20), and this 
may be related to the selective enhancement in mesocortical DA uti l ization 
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produced by acute footshock stress (21). Future experiments comparing the 
long-term effects of stimulants and stress on mesotelencephalic DA systems may 
yield interesting s imi lar i t ies.  I f  both stimulants and stress are found to 
produce an enduring up-regulation of brain DA systems this may help explain why 
both are precipitating factors in psychiatric disorders thought to involve 
brain catecholamine dysfunction (2, 3, 5, 22). 
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